Posted by on Nov 3, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the combination of ibrutinib with fludarabine, cyclophosphamide, and rituximab (FCR) as a frontline treatment in young, fit patients with chronic lymphocytic leukemia.  This study concluded that this combination is promising as a...

Read More